Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Demographics and Clinical Decision Making in Patients with Germline Moderate Penetrance Non-BRCA Mutations in Breast Cancer Related Genes. | Ann Surg Oncol | 2024 | 38976158 | PubTator, text mining | PubMed |
| FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer. | EMBO Mol Med | 2024 | 38956205 | PubTator, text mining | PubMed |
| Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men. | Res Sq | 2024 | 38947031 | PubTator, text mining | PubMed |
| Management and Clinical Outcomes of Breast Cancer in Women Diagnosed with Hereditary Cancer Syndromes in a Clinic-Based Sample from Colombia. | Cancers (Basel) | 2024 | 38893140 | PubTator, text mining | PubMed |
| Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients. | Hum Genomics | 2024 | 38890714 | PubTator, text mining | PubMed |
| Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients. | Breast Cancer Res Treat | 2024 | 38814507 | PubTator, text mining | PubMed |
| BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis. | Nat Commun | 2024 | 38769345 | PubTator, text mining | PubMed |
| Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis. | Oncologist | 2024 | 38716772 | PubTator, text mining | PubMed |
| Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery. | Biomedicines | 2024 | 38672070 | PubTator, text mining | PubMed |
| Correlation of BARD1 gene polymorphisms with risk of neuroblastoma: a meta-analysis. | Nucleosides Nucleotides Nucleic Acids | 2024 | 38619196 | PubTator, text mining | PubMed |
| Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study. | Breast Cancer Res Treat | 2024 | 38491334 | PubTator, text mining | PubMed |
| BARD1 deletion in a patient with suspected hereditary colorectal cancer. | Hum Genome Var | 2024 | 38485918 | PubTator, text mining | PubMed |
| Editorial expression of concern. | Sci Adv | 2024 | 38478625 | PubTator, text mining | PubMed |
| Germline structural variation globally impacts the cancer transcriptome including disease-relevant genes. | Cell Rep Med | 2024 | 38442712 | PubTator, text mining | PubMed |
| Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer. | Transl Oncol | 2024 | 38432114 | PubTator, text mining | PubMed |
| Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents-To Test or not to Test? | Clin Cancer Res | 2024 | 38411636 | PubTator, text mining | PubMed |
| Next-generation sequencing-based analysis of homologous recombination repair gene variant in ovarian cancer. | Heliyon | 2024 | 38298632 | PubTator, text mining | PubMed |
| A genome-wide association study reveals the relationship between human genetic variation and the nasal microbiome. | Commun Biol | 2024 | 38291185 | PubTator, text mining | PubMed |
| The ORFIUS complex regulates ORC2 localization at replication origins. | NAR Cancer | 2024 | 38288445 | PubTator, text mining | PubMed |
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population. | J Transl Med | 2024 | 38280995 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=12